Raphael Pharmaceutical (Raphael Pharmaceutical) Construction In Progress : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Raphael Pharmaceutical Construction In Progress?

Raphael Pharmaceutical Construction In Progress Historical Data

The historical data trend for Raphael Pharmaceutical's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raphael Pharmaceutical Construction In Progress Chart

Raphael Pharmaceutical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Raphael Pharmaceutical Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Construction In Progress	Get a 7-Day Free Trial								-	-	-	-	-

Raphael Pharmaceutical Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Raphael Pharmaceutical (Raphael Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Raphael Pharmaceutical Inc (OTCPK:RAPH) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Lui Paster, Tel Aviv-Jaffa, ISR, 6803605

Website

https://www.raphaelpharmaceutical.com

Raphael Pharmaceutical Inc is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil.

Executives

Joseph Press	director	4 LUI PASTER, TEL AVIV-JAFFA L3 6803605
Shlomo Pilo	director, 10 percent owner, officer: Chief Executive Officer	4 LUI PASTER, TEL AVIV L3 6803605
Hayon Igal Louria	director, officer: Chief Technology Officer	4 LUI PASTER, TEL AVIV-JAFFA L3 6803605
Yehuda Eliya	director	4 LUI PASTER, TEL AVIV-JAFFA L3 6803605
Robert B Catell	director	62 OSBORNE ROAD, GARDEN CITY NY 11530
Elisha Yanay	director	C/O ADVANCED TECHNOLOGY ACQUISITION CORP, 14 A ACHIMEIR STREET, RAMAT GAN L3 52587
Yacov A Shamash	director
Guy Ofir	director, 10 percent owner, officer: President	40 BAZ STREET, KARMIEL L3 20100
Emanuel Cohen	director, 10 percent owner, officer: Secretary Treasurer Director	51 BILU STREET, RA'ANANA L3 00000

Raphael Pharmaceutical (Raphael Pharmaceutical) Headlines

No Headlines